News Hub | News Direct

All Industries


Article thumbnail News Release

Real Advantage: Prop-Firm Offering Real Brokerage Accounts

Benzinga

By Austin DeNoce, Benzinga The trading landscape is characterized by an incredibly diverse marketplace. Proprietary trading firms (prop firms) are just one of its many innovations that have provided a pivotal path for ambitious traders seeking to leverage extensive capital, advanced tools and the wisdom of seasoned professionals. However, the journey from a novice to a seasoned trader involves a crucial choice between trading in a simulation account (SIM) and stepping into the real arena with a real brokerage account through a prop-firm. This decision can significantly impact a trader's development, strategy execution and psychological readiness for the market's challenges. Trading Real Money With Real Brokerage Accounts Through Prop Firms Trading through a real brokerage account unlocks a thrilling world where precision, real-time decision-making and genuine market forces all intersect. Here, every trade has tangible consequences reflected in your very real money. Profits earned are profits received and paper losses aren’t so fictional anymore. This prospect is exciting to some and terrifying to others, but if you’re a serious trader, this is the only path forward. So it is important to bear in mind the advantages of trading through a real account: Direct market engagement: Real accounts provide a more accurate and reliable data feed, which is essential for making informed decisions and practicing real-time decision-making. Quick payouts: Successful trades can generally be liquidated as soon as the next day, enabling a straightforward cashout process to enjoy your profits. Unrestricted trading styles: Real accounts typically offer fewer restrictions on trading strategies, allowing for a broader range of tactics, from high-frequency trading to long-term positions. Regulatory clarity: Every transaction is recorded and traders receive comprehensive reports that provide useful data and clarity as well as trust in the trading process. Technological edge: Real accounts leverage superior computing resources and bandwidth to ensure high performance and reliability throughout your trading. The Limitations Of SIM Account-Only Prop Firms While SIM accounts serve as valuable training grounds, they come with notable drawbacks that can hinder a trader's growth and realistic understanding of market dynamics. For instance, consistency rules can limit the potential for large trades since prop firms often have to pay out of their own pocket for SIM accounts, and some prop firms also encourage users to open multiple accounts – resulting in higher costs for the trader. Below are some other considerations to keep in mind when not using a real brokerage account: Withdrawals of profit: Here you will meet a lot of rules you must follow in order to get a payout. You have to be trading a certain number of days and can only request payout on specific dates. Then there are rules about consistency and limits to the amount you can take out. Prop firms can deny you payouts because you traded through news or earnings. There are a lot of different rules just to make it harder for you to get your hard earned money. Artificial trading environment: SIM accounts often operate under a set of restrictive rules that may not accurately reflect real market conditions, limiting the potential for practical development and experience. Delayed execution: The computing and bandwidth resources allocated to SIM accounts are typically inferior to those of live servers, potentially affecting trade execution. This, again, can distance you from the real experience and skills you need to succeed as a trader. Psychological dissonance: The lack of real financial risk can lead to complacency, impacting a trader's ability to handle real market pressures related to fear and greed. No matter how prepared you think you are, introducing real money changes everything, and you need to be prepared to handle that. BluSky: Paving a Path To Real Market Success BluSky Trading Company is a leading proprietary trading firm for traders seeking to make a seamless transition from the simulated world to the tangible pressures and opportunities of real market trading. With a focus on fostering trader development, BluSky offers a compelling package for those ready to embrace the challenges and rewards of real brokerage accounts: Payout rules: These are simple; what is your balance and how much buffer do you need to keep trading. No limiting rules. Simplified transition: Passing BluSky's evaluation with a maximum of 25% consistency allows traders to reclaim their first month's subscription fee; a unique incentive to commit to real trading. Enhanced trading capacity: Once in a brokerage account, traders have the opportunity to expand their trading arsenal with more contracts, bypassing the need for further evaluations. Personalized coaching: BluSky also stands out by offering one-on-one coaching for brokerage account holders, ensuring traders have the support and guidance to refine their strategies and mindset. Free live trade room: You benefit from the expertise of a professional trader who invests their own money. Engage freely, ask questions, and participate in special educational events at no additional cost. Beyond the bell: Follow BluSky’s post-market YouTube show, where you can continue learning from a seasoned trader and coach. Real Success Requires Real Trading Choosing to work with a prop firm using real brokerage accounts is crucial for any trader focused on professional advancement and financial achievement. The advantages of real trading - such as enhanced data feeds, regulatory clarity, and supporting educational initiatives - far surpass any involvement of prop firms using simulated environments. Prop firms like BluSky aim to provide a well-defined route to authentic trading experiences, supported by top-notch technology and exceptional guidance. This makes the journey into professional trading more accessible than ever. For those ready to tackle the challenges and seize the opportunities of a real brokerage account, this transition not only fosters professional growth, but also unlocks the vast potential of the financial markets. Featured photo by Chris Liverani on Unsplash. Benzinga is a leading financial media and data provider, known for delivering accurate, timely, and actionable financial information to empower investors and traders. This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice. Contact Details Benzinga +1 877-440-9464 info@benzinga.com Company Website http://www.benzinga.com

May 09, 2024 08:30 AM Eastern Daylight Time

Image
Article thumbnail News Release

Artemis Resources says Mt Marie prospect is fast becoming a 'priority one target' for lithium

Artemis Resources Ltd

Artemis Resources Ltd (ASX:ARV, AIM:ARV, OTCQB:ARTTF) executive director George Ventouras highlights promising results from latest sample assays from the Mt Marie lithium prospect in the Pilbara region of Western Australia. Ventouras expressed excitement over recent high-grade findings at Mt Marie, describing it as a priority target due to consistent high-grade assay results. He also noted encouraging results from Osborn East, showing consistency with yields above half a percent, though not as high as Mt Marie, but demonstrating potential in terms of strike length. The next steps for Artemis include awaiting heritage clearances for Mt Marie, with drilling expected to commence early in the new financial year around July or August. Ventouras detailed plans for extensive ground reconnaissance and sampling to further understand the lithium mineralisation and prepare for the drilling phase. Additionally, Artemis announced a fundraising initiative, the proceeds of which will support the lithium exploration and development of its gold prospects, with Lulu Creek also highlighted as a priority. The focus is on advancing these projects and enhancing the understanding of the geology to optimise exploration efforts. Contact Details Jonathan Jackson +61 413 713 744 jonathan@proactiveinvestors.com

May 09, 2024 07:46 AM Eastern Daylight Time

Video
Article thumbnail News Release

First Tin advances strategic tin projects in Australia and Germany to fill supply deficit

First Tin PLC

First Tin PLC CEO Bill Scotting joins Proactive's Stephen Gunnion with details of the two tin mining projects the company is developing in Australia and Germany. Scotting said the Taronga project, near Brisbane, will operate as an open pit mine and is expected to produce approximately 3,500 tonnes of tin concentrate annually. The German project, Tellerhäuser is being developed as an underground mine and will target multiple metals, including tin, indium, copper, and zinc. Both projects are situated in historic tin mining districts, with the German site dating back centuries. Scotting said technological advancements in mining and processing have enabled more efficient extraction and processing of tin. Market dynamics, such as increased tin pricing, have also improved the economic viability of these projects. Additionally, he noted that First Tin implements high environmental standards in its operations, including the use of solar power in Australia and adherence to strict environmental regulations in both countries. Scotting highlighted the growing global demand for tin, driven by its critical role in electronic manufacturing and the energy transition, including solar energy and electric vehicles. He noted a structural change in the market, with increasing tin usage in various high-tech applications. He also pointed out the strategic advantage of their mines' locations in OECD countries, which ensures a more stable and secure supply chain compared to tin sources in emerging economies. Contact Details Proactive UK Proactive UK +44 20 7989 0813 UKEditorial@proactiveinvestors.com

May 09, 2024 07:41 AM Eastern Daylight Time

Video
Article thumbnail News Release

Eden Research reports strong growth and new product introductions in 2023

Eden Research PLC

Eden Research PLC CEO Sean Smith tells Proactive's Stephen Gunnion the company achieved significant advancements and a robust performance in 2023. Revenue for the year to 31 December 2023 increased by 78% to £3.2 million, surpassing market expectations. This growth was attributed to strong sales across various product lines. A noteworthy development was a successful fundraising event that raised £9.9 million, enhancing the firm's cash position and enabling further product development. In partnership with Corteva Agriscience, Eden introduced Ecovelex, a new seed treatment product designed to repel birds from maize, marking a new category for the company. This product received temporary approval in Italy, facilitating its use in the 2024 growing season. Additionally, Eden expanded its product range to include an insecticide targeting pests like mites and aphids, which has undergone extensive field testing with over 140 trials worldwide. Regulatory approvals for Mevalone were a significant focus, with expansions in the US including crucial approval in California, important for the grapevine fungicide market. Looking forward, Smith said the company is optimistic about 2024, despite potential challenges from climate conditions and regulatory dependencies. Key future developments include ongoing product label expansions and regulatory authorisations, particularly in Europe. Contact Details Proactive UK Ltd +44 20 7989 0813 uk@proactiveinvestors.com

May 09, 2024 07:39 AM Eastern Daylight Time

Video
Article thumbnail News Release

Genflow Biosciences advances three major programs in fight against ageing diseases

Genflow Biosciences PLC

Genflow Biosciences PLC CE Dr Eric Leire tells Proactive's Stephen Gunnion the company had a successful year in 2023, allowing it to expand its research and development pipeline. Leire highlighted three main programs during an interview. The first focuses on MASH (Metabolic Dysfunction-Associated Steatohepatitis), soon progressing to clinical trials, indicating a strong move towards addressing liver diseases. The second program deals with Werner Syndrome, a progeria-related condition, where Genflow is innovating with synthetic organoids to mimic human organ function for better clinical trial predictions. The third program targets sarcopenia in collaboration with Revatis SA, aiming to combat muscle loss associated with ageing. The company has also engaged with regulatory agencies in Europe and the US, receiving positive feedback on its approach, particularly with its MASH program. It is awaiting further feedback from the FDA to decide the trial's location. In addition to a recent £715,000 fundraise, Genflow's financial strategy relies heavily on grants, with recent significant funding from the Wallonia Region in Belgium, which Leire believes positions it well to continue its work without heavy reliance on venture capital. Contact Details Proactive UK Ltd +44 20 7989 0813 uk@proactiveinvestors.com

May 09, 2024 07:37 AM Eastern Daylight Time

Video
Article thumbnail News Release

Fah Mai Holdings' Jacob Carter provides expert insights on whisky investment

Fah Mai Holdings Group Inc

Fah Mai Holdings Group Inc (OTC:FMHG) UK head and manager of @whiskybullauctions Jacob Carter provides detailed advice for investors in the secondary whisky bottle market in an interview with Proactive's Stephen Gunnion. Carter emphasised the importance of conducting thorough research and developing a personal investment strategy, highlighting rarity and age as key factors in choosing investment bottles. He mentioned significant past investment successes, such as a 1964 Black Bowmore Aston Martin DB5 bottle bought for less than £100 and now valued at about £50,000. Carter advised using resources like Rare Whisky 101 to access data on highly traded bottles and stressed the necessity of understanding market dynamics, which can be influenced by distillery release schedules and other seasonal factors. He also discussed the critical aspects of storage and insurance for investment bottles, suggesting that collectors work with auction houses that provide these services. Authenticity verification, according to Carter, can involve checking cask and bottle numbers or consulting with distilleries directly. Contact Details Proactive UK +44 20 7989 0813 UKEditorial@proactiveinvestors.com

May 09, 2024 07:08 AM Eastern Daylight Time

Video
Article thumbnail News Release

Seeing Machines advances with strategic expansions and strong quarterly performance

Seeing Machines Ltd

Seeing Machines Ltd CEO Paul McGlone joins Proactive's Stephen Gunnion with an update on the company's progress and key developments. McGlone highlighted the expansion with an existing US customer and a tier 1 supplier, driven by increasing regulatory requirements in Europe, which signifies a significant development for the company. This expansion includes new technology integrations and a stronger foothold in the European market, alongside additional volume in China. Further, McGlone discussed the company's recent performance following their third-quarter results, noting a return to normal production levels and the launch of a new major vehicle program. This contributed to Seeing Machines producing over 300,000 vehicles in the quarter, supporting a year-on-year growth rate of 100%. This performance reassured investors of the company's growth trajectory. Additionally, McGlone outlined the launch of their biggest ever production award with a significant European OEM, which includes a comprehensive interior sensing capability for driver and occupant monitoring. This project is seen as a major technical achievement and is expected to notably increase growth rates. McGlone also touched on the aftermarket segment, particularly their Guardian Connections system for trucks and buses, which showed consistent growth and is set to expand further with the rollout of their third-generation product. Lastly, McGlone reaffirmed the company's financial targets for 2024 and their aim to achieve cash break-even in 2025, indicating strong momentum across various business areas, including automotive, aviation, and fleet services. Contact Details Proactive UK Ltd +44 20 7989 0813 uk@proactiveinvestors.com

May 09, 2024 07:06 AM Eastern Daylight Time

Video
Article thumbnail News Release

Light Science Technologies CEO discusses record 2023 results and strategic growth

Light Science Technologies Holdings PLC

Light Science Technologies Holdings PLC (AIM:LST) reported a record year in 2023 with CEO Simon Deacon highlighting significant achievements in an interview with Proactive's Stephen Gunnion. The company implemented a strategic plan focused on growth and profitability, exceeding expectations in both areas. Notably, its Controlled Environment Agriculture (CEA) segment and Contract Electronics Manufacturing (CEM) contributed robustly to revenue increases. The company achieved a gross margin of 23.4% and overall revenue growth of 13.8% to £9.3 million. Deacon also discussed the impact of strategic acquisitions, including Tomtech, which enhanced its offerings in controlled environment agriculture, integrating systems for vertical farms, polytunnels, and glasshouses. Another notable acquisition was Injecta Fire Barrier, a key asset in the passive fire protection market, poised for growth due to regulatory changes spurred by the Fire Safety Act of 2021. Additionally, the CEO outlined the use of a £1.45 million fundraise to support product development, acquisitions, and extend its cash runway. Looking forward, Deacon detailed milestones for 2024, including a significant contract in the sports entertainment electronics segment and anticipated revenue growth in passive fire protection. Overall, Deacon remains optimistic about sustaining momentum and achieving further growth. Contact Details Proactive UK Ltd +44 20 7989 0813 uk@proactiveinvestors.com

May 09, 2024 07:03 AM Eastern Daylight Time

Video
Article thumbnail News Release

Immunic CEO Dr Daniel Vitt discusses key Q1 advances and upcoming milestones

Immunic Inc

Immunic Inc (NASDAQ:IMUX) CEO Dr Daniel Vitt takes Proactive's Stephen Gunnion through the company's first-quarter achievements and upcoming milestones for its clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases. Vitt said the quarter was notable for Immunic's successful fundraising efforts, raising up to $240 million in a three-tranche private placement aimed at furthering its Multiple Sclerosis (MS) and gastrointestinal treatments. He also highlighted the importance of the recent allowance of a fourth US patent for vidofludimus calcium, enhancing its intellectual property portfolio around MS treatments and ensuring long-term commercial exclusivity. Vitt gave an update on the status of ongoing clinical trials, including the advanced Phase 2 CALLIPER trial for MS, with significant results expected in April next year. Moreover, he touched on Immunic's gastrointestinal disorder programs, particularly for celiac disease, with the IMU-856 program showing promising results in restoring gut wall functions. The interview also covered upcoming milestones, focusing on executing current clinical trials and preparing for future phases. Contact Details Proactive North America +1 604-688-8158 NA-editorial@proactiveinvestors.com

May 09, 2024 06:58 AM Eastern Daylight Time

Video
1 ... 192193194195196 ... 3738